Ristocetin A (sulfate)

Description: Ristocetin A, a glycopeptide related to vancomycin, is an antibiotic produced by the microorganism Nocardia lurida[1]. Target: Others. Smiles: OS(O)(=O)=O.COC(=O)C1NC(=O)C2NC(=O)C(NC(=O)C3NC(=O)C4NC(=O)C(NC(=O)C(N)c5ccc(O)c(Oc6cc4cc(O)c6C)c5)C(O)c4ccc(Oc5cc3cc(Oc3ccc(cc3)C2OC2CC(N)C(O)C(C)O2)c5OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2OC2OCC(O)C(O)C2O)cc4)c2ccc(O)c(c2)-c2c(OC3OC(CO)C(O)C(O)C3O)cc(O)cc12. References: Pearson A J, Heo J N. Approaches to the fully functionalized DEF ring system of ristocetin A via highly selective ruthenium-promoted SNAr reaction[J]. Organic letters, 2000, 2(19): 2987-2990. Hawks G H. Antibiotic therapy of staphylococcal infections[J]. Canadian Medical Association journal, 1965, 93(16): 848.